These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 31984676)

  • 1. Screening and confirmatory analysis of recombinant human erythropoietin for racing camels' doping control.
    Delcourt V; Garcia P; Chabot B; Loup B; Remy P; Popot MA; Bailly-Chouriberry L
    Drug Test Anal; 2020 Jun; 12(6):763-770. PubMed ID: 31984676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Recent advances in the detection of recombinant human erythropoiesis and its analogs in doping control].
    Yang X; Pang N; Liao Y; Liu H
    Se Pu; 2008 Jul; 26(4):413-6. PubMed ID: 18959234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel and innovative hair test to determine glucocorticoid levels in racing camels for use in assessment of doping, health, and disease.
    Shah I; Haddow JD; Ibrahim HA; Sheikh MVA; Alhemeiri FSA
    Drug Test Anal; 2018 Apr; 10(4):742-749. PubMed ID: 28994213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new analytical method based on anti-EPO monolith column and LC-FAIMS-MS/MS for the detection of rHuEPOs in horse plasma and urine samples.
    Bailly-Chouriberry L; Cormant F; Garcia P; Lönnberg M; Szwandt S; Bondesson U; Popot MA; Bonnaire Y
    Analyst; 2012 May; 137(10):2445-53. PubMed ID: 22454833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Doping control analysis of recombinant human erythropoietin, darbepoetin alfa and methoxy polyethylene glycol-epoetin beta in equine plasma by nano-liquid chromatography-tandem mass spectrometry.
    Yu NH; Ho EN; Wan TS; Wong AS
    Anal Bioanal Chem; 2010 Apr; 396(7):2513-21. PubMed ID: 20148243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Confirmatory analysis of continuous erythropoietin receptor activator and erythropoietin analogues in equine plasma by LC-MS for doping control.
    Guan F; Uboh CE; Soma LR; Maylin G; Jiang Z; Chen J
    Anal Chem; 2010 Nov; 82(21):9074-81. PubMed ID: 20945883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of cobalt for human sports drug testing purposes using ICP- and LC-ICP-MS.
    Knoop A; Planitz P; Wüst B; Thevis M
    Drug Test Anal; 2020 Nov; 12(11-12):1666-1672. PubMed ID: 33142033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Recent advances in the detection of human erythropoietin and human growth hormone doping].
    Guo L; Zhang Z; Tang J; Xie J
    Se Pu; 2008 Jul; 26(4):437-43. PubMed ID: 18959238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erythropoietin and erythropoiesis stimulating agents.
    Debeljak N; Sytkowski AJ
    Drug Test Anal; 2012 Nov; 4(11):805-12. PubMed ID: 22508651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of recombinant human EPO variants in greyhound plasma and urine by ELISA, LC-MS/MS and western blotting: a comparative study.
    Timms M; Steel R; Vine J
    Drug Test Anal; 2016 Feb; 8(2):164-76. PubMed ID: 26290355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erythropoietin and blood doping.
    Robinson N; Giraud S; Saudan C; Baume N; Avois L; Mangin P; Saugy M
    Br J Sports Med; 2006 Jul; 40 Suppl 1(Suppl 1):i30-4. PubMed ID: 16799100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Procedures for monitoring recombinant erythropoietin and analogues in doping control.
    Segura J; Pascual JA; Gutiérrez-Gallego R
    Anal Bioanal Chem; 2007 Aug; 388(7):1521-9. PubMed ID: 17516052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of darbepoetin alfa in human plasma by liquid chromatography coupled to mass spectrometry for doping control.
    Guan F; Uboh CE; Soma LR; Birksz E; Chen J
    Int J Sports Med; 2009 Feb; 30(2):80-6. PubMed ID: 19177313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Doping control analysis of filgrastim in equine plasma and its application to a co-administration study of filgrastim and recombinant human erythropoietin in the horse.
    Ho EN; Kwok WH; Lau MY; Wong AS; Lam KK; Stewart BD; Wan TS
    J Chromatogr A; 2014 Apr; 1338():92-101. PubMed ID: 24636755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liquid chromatography - high resolution mass spectrometry-based metabolomic approach for the detection of Continuous Erythropoiesis Receptor Activator effects in horse doping control.
    Joré C; Loup B; Garcia P; Paris AC; Popot MA; Audran M; Bonnaire Y; Varlet-Marie E; Bailly-Chouriberry L
    J Chromatogr A; 2017 Oct; 1521():90-99. PubMed ID: 28941809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A high-throughput test to detect C.E.R.A. doping in blood.
    Lamon S; Giraud S; Egli L; Smolander J; Jarsch M; Stubenrauch KG; Hellwig A; Saugy M; Robinson N
    J Pharm Biomed Anal; 2009 Dec; 50(5):954-8. PubMed ID: 19625154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The analytical approach for detection of carbamylated erythropoietin for doping control purposes.
    Kaliszewski P; Siek P; Zalewska Z; Michalak D; Kwiatkowska D
    Drug Test Anal; 2020 Nov; 12(11-12):1599-1604. PubMed ID: 33119952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive metabolite profiling of trimetazidine in camels using high-resolution accurate mass spectrometry: Implications for doping control.
    Nalakath J; Pt R; Kadry A; Palathinkal AB; Praseen OK; Nelliyott I; Hebel C; Selvapalam N; Nagarajan ER
    Rapid Commun Mass Spectrom; 2023 Nov; 37(21):e9626. PubMed ID: 37799033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of in vitro generated metabolites of LGD-4033, a selective androgen receptor modulator, in homogenized camel liver for anti-doping applications.
    Ondern Komathu P; Padusha MKSA; Laya S; Nalakath J; Palathinkal AB; Nelliyott I
    Rapid Commun Mass Spectrom; 2023 Nov; 37(22):e9633. PubMed ID: 37817338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blood cells RNA biomarkers as a first long-term detection strategy for EPO abuse in horseracing.
    Bailly-Chouriberry L; Noguier F; Manchon L; Piquemal D; Garcia P; Popot MA; Bonnaire Y
    Drug Test Anal; 2010 Jul; 2(7):339-45. PubMed ID: 20687115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.